$431 Million is the total value of Parkman Healthcare Partners LLC's 83 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 50.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ACRS | Sell | ACLARIS THERAPEUTICS INC | $43,070,000 | +255.0% | 1,709,136 | -8.9% | 10.00% | +221.5% |
| QQQ | New | INVESCO QQQ TRput | $15,957,000 | – | 50,000 | +100.0% | 3.70% | – |
| DHR | Buy | DANAHER CORPORATION | $14,627,000 | +38.1% | 64,985 | +36.3% | 3.40% | +25.1% |
| CRL | Buy | CHARLES RIV LABS INTL INC | $14,492,000 | +46.2% | 50,000 | +26.1% | 3.36% | +32.5% |
| NTRA | Buy | NATERA INC | $14,205,000 | +18.1% | 139,893 | +15.7% | 3.30% | +7.0% |
| HUM | Buy | HUMANA INC | $13,835,000 | +35.9% | 33,000 | +33.0% | 3.21% | +23.1% |
| ICAD | Buy | ICAD INC | $13,753,000 | +92.0% | 648,131 | +19.4% | 3.19% | +74.0% |
| DXCM | Sell | DEXCOM INC | $13,555,000 | -11.7% | 37,718 | -9.2% | 3.15% | -20.0% |
| IQV | Buy | IQVIA HLDGS INC | $12,757,000 | +22.3% | 66,048 | +13.4% | 2.96% | +10.8% |
| UTHR | New | UNITED THERAPEUTICS CORP DEL | $12,524,000 | – | 74,874 | +100.0% | 2.91% | – |
| CDMO | Sell | AVID BIOSERVICES INC | $12,305,000 | +42.3% | 675,000 | -9.9% | 2.86% | +28.9% |
| AMGN | New | AMGEN INC | $11,211,000 | – | 45,059 | +100.0% | 2.60% | – |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $9,183,000 | +95.4% | 65,043 | +79.9% | 2.13% | +77.0% |
| RCUS | Buy | ARCUS BIOSCIENCES INC | $8,870,000 | +47.4% | 315,882 | +36.3% | 2.06% | +33.6% |
| XLRN | Buy | ACCELERON PHARMA INC | $8,514,000 | +26.9% | 62,780 | +19.7% | 1.98% | +15.0% |
| CTLT | Sell | CATALENT INC | $8,375,000 | -4.3% | 79,526 | -5.5% | 1.94% | -13.3% |
| PODD | Buy | INSULET CORP | $8,133,000 | +4.0% | 31,169 | +1.9% | 1.89% | -5.7% |
| ITMR | Buy | ITAMAR MED LTDsponsored ads | $8,057,000 | +43.7% | 336,429 | +19.2% | 1.87% | +30.1% |
| DRNA | Sell | DICERNA PHARMACEUTICALS INC | $7,755,000 | +6.2% | 303,268 | -8.5% | 1.80% | -3.8% |
| AVTR | Buy | AVANTOR INC | $7,295,000 | +71.8% | 252,163 | +67.1% | 1.69% | +55.6% |
| XENE | Buy | XENON PHARMACEUTICALS INC | $6,702,000 | +20.5% | 374,395 | +3.5% | 1.56% | +9.1% |
| ONCT | Buy | ONCTERNAL THERAPEUTICS INC | $6,479,000 | +251.0% | 778,785 | +106.7% | 1.50% | +218.0% |
| IMUX | Buy | IMMUNIC INC | $6,395,000 | +14.1% | 401,218 | +9.4% | 1.48% | +3.3% |
| HZNP | Sell | HORIZON THERAPEUTICS PUB L | $6,298,000 | -51.0% | 68,430 | -61.1% | 1.46% | -55.6% |
| VCEL | Sell | VERICEL CORP | $6,111,000 | -50.6% | 110,000 | -72.6% | 1.42% | -55.3% |
| INFU | Buy | INFUSYSTEM HLDGS INC | $5,677,000 | +25.2% | 278,833 | +15.5% | 1.32% | +13.4% |
| GOSS | Buy | GOSSAMER BIO INC | $5,392,000 | +59.0% | 582,890 | +66.2% | 1.25% | +44.0% |
| EDAP | Buy | EDAP TMS S Asponsored adr | $4,816,000 | +616.7% | 573,374 | +341.4% | 1.12% | +550.0% |
| IONS | Buy | IONIS PHARMACEUTICALS INC | $4,757,000 | +11.6% | 105,797 | +40.3% | 1.10% | +1.1% |
| ARWR | Sell | ARROWHEAD PHARMACEUTICALS IN | $4,648,000 | -52.4% | 70,089 | -44.9% | 1.08% | -56.8% |
| MDGL | Buy | MADRIGAL PHARMACEUTICALS INC | $4,646,000 | +222.0% | 39,721 | +206.1% | 1.08% | +191.4% |
| STRO | Sell | SUTRO BIOPHARMA INC | $4,613,000 | -20.3% | 202,696 | -24.0% | 1.07% | -27.8% |
| STXS | Buy | STEREOTAXIS INC | $4,542,000 | +37.8% | 675,922 | +4.4% | 1.05% | +24.9% |
| AXGN | Sell | AXOGEN INC | $4,287,000 | +3.9% | 211,599 | -8.2% | 1.00% | -5.9% |
| BBIO | Sell | BRIDGEBIO PHARMA INC | $4,015,000 | -25.9% | 65,174 | -14.4% | 0.93% | -32.8% |
| MRVI | Buy | MARAVAI LIFESCIENCES HLDGS I | $4,010,000 | +29.6% | 112,500 | +2.0% | 0.93% | +17.6% |
| NUAN | Sell | NUANCE COMMUNICATIONS INC | $3,979,000 | -22.0% | 91,173 | -21.2% | 0.92% | -29.4% |
| KOD | Sell | KODIAK SCIENCES INC | $3,747,000 | -48.9% | 33,048 | -33.8% | 0.87% | -53.7% |
| IDXX | Buy | IDEXX LABS INC | $3,734,000 | -1.6% | 7,632 | +0.5% | 0.87% | -10.9% |
| OM | Buy | OUTSET MED INC | $3,535,000 | +120.4% | 65,000 | +130.4% | 0.82% | +99.5% |
| SPNE | Sell | SEASPINE HLDGS CORP | $3,319,000 | -49.3% | 190,747 | -49.1% | 0.77% | -54.1% |
| KDMN | Sell | KADMON HLDGS INC | $3,207,000 | -17.3% | 824,475 | -11.8% | 0.74% | -25.2% |
| XRAY | New | DENTSPLY SIRONA INC | $3,191,000 | – | 50,000 | +100.0% | 0.74% | – |
| SDGR | Sell | SCHRODINGER INC | $3,086,000 | -75.0% | 40,453 | -74.1% | 0.72% | -77.4% |
| HCAT | Sell | HEALTH CATALYST INC | $3,053,000 | -6.5% | 65,274 | -13.0% | 0.71% | -15.3% |
| COO | New | COOPER COS INC | $2,881,000 | – | 7,500 | +100.0% | 0.67% | – |
| BCRX | Sell | BIOCRYST PHARMACEUTICALS INC | $2,488,000 | -38.0% | 244,680 | -54.6% | 0.58% | -43.9% |
| JAZZ | New | JAZZ PHARMACEUTICALS PLC | $2,466,000 | – | 15,000 | +100.0% | 0.57% | – |
| ETNB | Buy | 89BIO INC | $2,419,000 | +2.7% | 102,163 | +5.7% | 0.56% | -7.1% |
| BCEL | Buy | ATRECA INC | $2,330,000 | +14.3% | 151,993 | +20.4% | 0.54% | +3.6% |
| CDXS | New | CODEXIS INC | $2,289,000 | – | 100,000 | +100.0% | 0.53% | – |
| BCYC | New | BICYCLE THERAPEUTICS PLCsponsored ads | $2,254,000 | – | 75,454 | +100.0% | 0.52% | – |
| CRIS | Buy | CURIS INC | $2,219,000 | +38.9% | 195,991 | +0.5% | 0.52% | +25.9% |
| MTEM | Buy | MOLECULAR TEMPLATES INC | $2,093,000 | +39.3% | 165,825 | +3.6% | 0.49% | +26.2% |
| CBIO | Buy | CATALYST BIOSCIENCES INC | $1,974,000 | +65.3% | 391,618 | +107.0% | 0.46% | +49.7% |
| SURF | Buy | SURFACE ONCOLOGY INC | $1,968,000 | +21.2% | 252,244 | +43.5% | 0.46% | +9.9% |
| HAE | New | HAEMONETICS CORP MASS | $1,943,000 | – | 17,500 | +100.0% | 0.45% | – |
| ONEM | Sell | 1LIFE HEALTHCARE INC | $1,767,000 | -46.0% | 45,217 | -39.7% | 0.41% | -51.1% |
| PROF | Buy | PROFOUND MED CORP | $1,700,000 | +19.7% | 84,399 | +22.2% | 0.40% | +8.5% |
| REPH | New | RECRO PHARMA INC | $1,679,000 | – | 601,967 | +100.0% | 0.39% | – |
| Sell | TRILLIUM THERAPEUTICS INC | $1,614,000 | -33.3% | 150,304 | -8.7% | 0.38% | -39.5% | |
| PFMT | New | PERFORMANT FINL CORP | $1,613,000 | – | 750,000 | +100.0% | 0.37% | – |
| ATEC | Sell | ALPHATEC HLDGS INC | $1,579,000 | -78.4% | 100,000 | -80.1% | 0.37% | -80.4% |
| MNKD | New | MANNKIND CORP | $1,568,000 | – | 400,000 | +100.0% | 0.36% | – |
| NOTV | New | INOTIV INC | $1,500,000 | – | 75,000 | +100.0% | 0.35% | – |
| KNSA | Buy | KINIKSA PHARMACEUTICALS LTD | $1,492,000 | +12.6% | 80,603 | +7.5% | 0.35% | +2.1% |
| FULC | New | FULCRUM THERAPEUTICS INC | $1,481,000 | – | 125,738 | +100.0% | 0.34% | – |
| TPTX | Sell | TURNING POINT THERAPEUTICS I | $1,321,000 | -81.7% | 13,962 | -76.5% | 0.31% | -83.4% |
| ARPO | Buy | AERPIO PHARMACEUTICALS INC | $1,292,000 | +398.8% | 1,001,189 | +278.7% | 0.30% | +354.5% |
| TLMD | New | SOC TELEMED INC | $1,208,000 | – | 192,127 | +100.0% | 0.28% | – |
| BLRX | Buy | BIOLINERX LTDsponsored ads | $1,200,000 | +11.3% | 430,109 | +0.5% | 0.28% | +1.1% |
| PHAT | New | PHATHOM PHARMACEUTICALS INC | $1,135,000 | – | 30,207 | +100.0% | 0.26% | – |
| ASLN | New | ASLAN PHARMACEUTICALS LTDads | $1,089,000 | – | 325,000 | +100.0% | 0.25% | – |
| FBRX | Buy | FORTE BIOSCIENCES INC | $1,071,000 | -5.4% | 31,256 | +0.5% | 0.25% | -14.1% |
| SILK | Sell | SILK RD MED INC | $1,013,000 | -76.3% | 20,000 | -70.5% | 0.24% | -78.5% |
| KALA | Sell | KALA PHARMACEUTICALS INC | $1,000,000 | -45.9% | 148,433 | -45.5% | 0.23% | -51.0% |
| KRMD | Sell | REPRO MED SYS INC | $921,000 | -78.2% | 261,722 | -62.7% | 0.21% | -80.2% |
| RAPT | Buy | RAPT THERAPEUTICS INC | $896,000 | +80.3% | 40,364 | +60.3% | 0.21% | +63.8% |
| CSLT | New | CASTLIGHT HEALTH INCcl b | $756,000 | – | 500,393 | +100.0% | 0.18% | – |
| AUPH | Sell | AURINIA PHARMACEUTICALS INC | $644,000 | -48.0% | 49,581 | -44.6% | 0.15% | -53.0% |
| BFLY | New | BUTTERFLY NETWORK INC | $510,000 | – | 30,315 | +100.0% | 0.12% | – |
| APEN | New | APOLLO ENDOSURGERY INC | $413,000 | – | 75,000 | +100.0% | 0.10% | – |
| EYEG | New | EYEGATE PHARMACEUTICALS INC | $375,000 | – | 75,295 | +100.0% | 0.09% | – |
| PHAS | Exit | PHASEBIO PHARMACEUTICALS INC | $0 | – | -110,547 | -100.0% | -0.10% | – |
| VSTM | Exit | VERASTEM INC | $0 | – | -251,449 | -100.0% | -0.14% | – |
| CNCE | Exit | CONCERT PHARMACEUTICALS INC | $0 | – | -50,290 | -100.0% | -0.16% | – |
| FATE | Exit | FATE THERAPEUTICS INC | $0 | – | -7,615 | -100.0% | -0.18% | – |
| SNDX | Exit | SYNDAX PHARMACEUTICALS INC | $0 | – | -31,386 | -100.0% | -0.18% | – |
| ALT | Exit | ALTIMMUNE INC | $0 | – | -100,000 | -100.0% | -0.29% | – |
| NEPH | Exit | NEPHROS INC | $0 | – | -167,048 | -100.0% | -0.37% | – |
| CSTL | Exit | CASTLE BIOSCIENCES INC | $0 | – | -22,831 | -100.0% | -0.39% | – |
| AVRO | Exit | AVROBIO INC | $0 | – | -121,018 | -100.0% | -0.43% | – |
| SDC | Exit | SMILEDIRECTCLUB INC | $0 | – | -175,691 | -100.0% | -0.54% | – |
| BMRN | Exit | BIOMARIN PHARMACEUTICAL INC | $0 | – | -25,000 | -100.0% | -0.56% | – |
| AXSM | Exit | AXSOME THERAPEUTICS INC | $0 | – | -30,758 | -100.0% | -0.64% | – |
| IMVT | Exit | IMMUNOVANT INC | $0 | – | -60,781 | -100.0% | -0.72% | – |
| EIDX | Exit | EIDOS THERAPEUTICS INC | $0 | – | -21,609 | -100.0% | -0.73% | – |
| ABBV | Exit | ABBVIE INC | $0 | – | -30,000 | -100.0% | -0.82% | – |
| MRSN | Exit | MERSANA THERAPEUTICS INC | $0 | – | -123,031 | -100.0% | -0.84% | – |
| NVAX | Exit | NOVAVAX INC | $0 | – | -34,498 | -100.0% | -0.99% | – |
| EW | Exit | EDWARDS LIFESCIENCES CORP | $0 | – | -50,584 | -100.0% | -1.18% | – |
| UNH | Exit | UNITEDHEALTH GROUP INC | $0 | – | -23,993 | -100.0% | -2.16% | – |
| GNMK | Exit | GENMARK DIAGNOSTICS INC | $0 | – | -617,722 | -100.0% | -2.31% | – |
| GWPH | Exit | GW PHARMACEUTICALS PLCads | $0 | – | -81,573 | -100.0% | -2.41% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| DEXCOM INC | 16 | Q3 2023 | 6.3% |
| ACLARIS THERAPEUTICS INC | 16 | Q3 2023 | 10.0% |
| XENON PHARMACEUTICALS INC | 16 | Q3 2023 | 3.3% |
| NATERA INC | 16 | Q3 2023 | 3.4% |
| AVID BIOSERVICES INC | 15 | Q3 2023 | 2.9% |
| SCHRODINGER INC | 15 | Q3 2023 | 4.2% |
| REPRO MED SYS INC | 15 | Q2 2023 | 2.0% |
| MANNKIND CORP | 15 | Q3 2023 | 1.6% |
| IQVIA HLDGS INC | 14 | Q1 2023 | 4.6% |
| INSULET CORP | 14 | Q3 2023 | 2.9% |
View Parkman Healthcare Partners LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| PLUS THERAPEUTICS, INC. | February 13, 2023 | 583,467 | 1.7% |
View Parkman Healthcare Partners LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-02-13 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
View Parkman Healthcare Partners LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.